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Abstract
Background: Gene regulation at transcript level can provide a good indication of the complex signaling mechanisms
underlying physiological and pathological processes. Transcriptomic methods such as microarray and quantitative real-
time PCR require stable reference genes for accurate normalization of gene expression. Some but not all studies have
shown that housekeeping genes (HGKs), b-actin (ACTB) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
which are routinely used for normalization, may vary significantly depending on the cell/tissue type and experimental
conditions. It is currently unclear if these genes are stably expressed in cells undergoing drastic morphological changes
during neuronal differentiation. Recent meta-analysis of microarray datasets showed that some but not all of the
ribosomal protein genes are stably expressed. To test the hypothesis that some ribosomal protein genes can serve as
reference genes for neuronal differentiation, a genome-wide analysis was performed and putative reference genes were
identified based on stability of expressions. The stabilities of these potential reference genes were then analyzed by
reverse transcription quantitative real-time PCR in six differentiation conditions.
Results: Twenty stably expressed genes, including thirteen ribosomal protein genes, were selected from microarray
analysis of the gene expression profiles of GDNF and NGF induced differentiation of PC12 cells. The expression
levels of these candidate genes as well as ACTB and GAPDH were further analyzed by reverse transcription
quantitative real-time PCR in PC12 cells differentiated with a variety of stimuli including NGF, GDNF, Forskolin, KCl
and ROCK inhibitor, Y27632. The performances of these candidate genes as stable reference genes were evaluated
with two independent statistical approaches, geNorm and NormFinder.
Conclusions: The ribosomal protein genes, RPL19 and RPL29, were identified as suitable reference genes during
neuronal differentiation of PC12 cells, regardless of the type of differentiation conditions. The combination of these
two novel reference genes, but not the commonly used HKG, GAPDH, allows robust and accurate normalization of
differentially expressed genes during PC12 differentiation.
Background
During development, neurons make networks of con-
nections with other neurons by growing axons and den-
drites. These neuronal out-growths are regulated by
extracellular cues that signal to cells resulting in pheno-
typic changes. A major challenge is the identification of
molecular mechanisms underlying this highly complex
and interactive network in terms of the functions of
genes and proteins[1].
Currently, transcriptomic methods are widely used as
an initial step in unraveling the complex signaling
mechanisms underlying physiological and pathological
processes and in neuronal differentiation [2-5]. Gene
microarray offers a high throughput platform for the
analysis of the entire transcriptome to identify differen-
tially expressed genes. Reverse transcription quantitative
real-time PCR (RT-qPCR), with a wider dynamic range
of quantification and higher assay sensitivity and
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any medium, provided the original work is properly cited.precision, is often used to corroborate microarray find-
ings [6,7]. Regardless of the method used, normalization,
a critical process of adjusting the expression measure-
ments between samples to compensate for various
sources of variability in the assay, is essential to allow
accurate comparisons of the results between different
samples and conditions [8,9]. Normalization with inter-
nal reference gene is used to control for technical and
biological variations introduced during both sample pre-
paration and detection by RT-qPCR [10]. It has also
been shown to be suitable for the normalization of par-
tially degraded RNA samples [11-13].
With nearly all normalization methods, the assump-
tion that one or more reference genes are constitutively
expressed at near-constant levels under all experimental
conditions is implicit and the expression levels of all
other genes in the sample are then scaled to these refer-
ence genes accordingly. It is common to use reference
genes selected from an assumed list of “housekeeping”
genes (HKGs) which typically include transcripts such
as GAPDH and ACTB [9,10,14]. A number of studies
have now shown that the expressions of these genes, in
some but not all experimental conditions, are altered
significantly[15-18], thus, making the choice of using
these HKGs for normalization uncertain without a priori
knowledge.
A variety of approaches have been employed to enable
better selection of reference genes. One approach is the
use of statistical algorithms, for example, geNorm [14],
Best keeper [19], NormFinder [20], Global Pattern
Recognition [21], and Equivalence tests [22], to evaluate
the relative expression stabilities of genes from a pool of
predefined lists of candidates. While this approach is
certainly more robust than using the single gene meth-
ods, it too is based on potentially unfounded assump-
tions about which genes may be stably expressed in the
conditions studied. These genes are still required to be
pre-selected and incorporated into the experimental
designs without any ap r i o r ievidence to support their
use. An alternative and less biased approach is the
meta-analysis of large scale gene expression profiles to
identify stably expressed genes [23-26]. A selected num-
ber of potential references genes can then be validated
experimentally and the stability of expressions analyzed
by the above mentioned statistical algorithms in defined
experimental settings.
To date, reference genes validated for neuronal differ-
entiation studies have not been reported yet. The pre-
sent study aims to identify suitable reference genes
during chemically induced neuronal differentiation of
PC12, a cell-line derived from a pheochromocytoma of
the rat adrenal medulla. Because of its unique cellular
properties, suitability for genetic and biochemical
manipulations, the PC12 cell-line is widely regarded as a
convenient alternative to endogenous neuronal cells,
and serves as a commonly used model system for stu-
dies on neuronal differentiation [27-29]. For example, in
response to NGF, PC12 cells stop dividing, elaborate
neuronal processes, are electrically excitable, and have
the potential to form synapses when co-cultured with
muscle cells [30]. Here, we measured the temporal
expression of twenty novel candidate reference genes
identified from microarray studies and the commonly
used HKGs, ACTB and GAPDH, at various stages of
PC12 differentiation. Based on two independent statisti-
cal approaches ["pairwise comparison” [14] and “model
based variation” [20], the expressions of ribosomal pro-
tein genes RPL19 and RPL29 were found to be highly
stable regardless of pharmacological treatments and
stages of differentiation. The combination of the two
reference genes was sufficient to allow robust and accu-
rate normalization of differentiation related genes.
Results
Selection of candidate reference genes from microarray
data
It has been suggested that suitable reference genes
should be expressed in all experimental conditions and
exhibit low coefficient of variation (CV) in their expres-
sions [25,26,31,32]. In order to identify such reference
genes, we first analyzed the expression profiles of 21,910
genes in naïve PC12 cells and those treated with NGF
or GDNF and found 8,568 genes to be expressed in all
conditions (detection p values < 0.05). We then analyzed
the top 100 genes with the lowest CV (0.8% -1.45%)
with two well accepted but different statistical
approaches, “pairwise comparison” (geNorm) and
“model based variation analysis” (NormFinder). The
“pairwise comparison” approach assumes that a perfect
pair of reference genes has a constant ratio across all
experimental conditions. As such, geNorm evaluates the
inter-conditional variability of the ratio between each
pair of reference genes and calculates a gene stability
measure M for each candidate [14]. However, with this
method, tightly co-regulated genes will appear to be
stable. The second algorithm, NormFinder, was
employed to safeguard against such a pitfall of misiden-
tifying expression invariant reference genes. This model-
based variance estimation approach entails analysis of
sample subgroups and calculates the variation of each
candidate gene individually, based on both intra- and
inter-group variation [20]. While geNorm measures rela-
tive stability, NormFinder measures absolute stability by
decomposing the variance to biological and technical
elements. With this method, the expressions of co-regu-
lated genes can be distinguished. Despite the differences
in algorithms and assumptions, both statistical methods
were in agreement on the identity of the twenty most
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purpose of normalization studies. Interestingly, thirteen
of these twenty candidate reference genes were riboso-
mal protein genes.
Real-time PCR validation of novel candidate reference
genes
As one of the most extensively studied models for neu-
ronal differentiation, PC12 cells respond to a broad
spectrum of pharmacological agents, which trigger a
myriad of intracellular signaling pathways leading to
neuronal differentiation. In order to verify the general
utility of the 20 selected putative reference genes (Table
1) in a broader range of experimental conditions, we dif-
ferentiated PC12 cells with other stimuli (Forskolin [33],
KCl [34] and ROCK inhibitor Y27632 [35]) in addition
t oN G Fa n dG D N F .G D N Fw a sa p p l i e dt oP C 1 2c e l l s
stably expressing GDNF Family Receptor alpha 1a
(GFRa1a) and co-receptor RET (either RET9 or RET51
isoforms), which are not endogenously expressed at
detectable levels in PC12 cells (data not shown). The
percentage of PC12 cells differentiated by the five che-
mical stimuli was quantified (Figure 1A) and the axon-
like features of the extended neurite were confirmed by
immunocytochemical analysis with anti-Neurofilament-
200 antibody (Figure 1B). The extent of neurite out-
growth was highly dependent on the stimuli used. NGF
and GDNF stimulation induced longer neurite out-
growths than Forskolin, KCl or Y27632. Total RNA was
collected at 0.5 h, 6 h, 24 h and 72 h from control and
treated cells for each stimuli, with biological triplicates,
that totaled 120 samples.
We analyzed the expression levels of the aforemen-
tioned twenty candidate reference genes, two most
commonly used HKGs (GAPDH and ACTB), and three
genes which are well known to be regulated by NGF
using RT-qPCR (Figure 2). The expression levels of the
twenty candidate reference genes and the two HKGs
span three orders of magnitude. These reference genes
were expressed at comparable levels or lower than the
HKGs examined. For accurate determination of inter-
assay variations and primer efficiencies, flanking
regions of the genes (~300 bp) were amplified by PCR,
sub-cloned and the sequences verified. These recombi-
nant plasmids were then linearized and served as tem-
plates to construct standard curves. All the qPCR
assays showed high efficiency of amplification (>90%)
and low intra- and inter-assay variations (Additional
Table 1 Selection of candidate reference genes from microarray data
Gene symbol Definition Mean geNorm NormFinder
RPL29 Ribosomal protein L29 14.04 1 1
RPL10a Ribosomal protein L10A 12.49 2 2
LOC292640 Vps20-associated 1 homolog 10.87 3 3
LOC498143 Similar to ribosomal protein L15 13.71 4 4
LOC317275 Similar to ribosomal protein L7-like 1 11.88 7 5
RPS15 Ribosomal protein S15 12.97 5 6
ARBP Acidic ribosomal phosphoprotein P0 14.27 6 7
RPL14 Ribosomal protein L14 13.89 9 8
EEF1A1 Eukaryotic translation elongation factor 1 alpha 1 14.17 8 9
RPS15A Ribosomal protein S15a 13.93 10 10
RPL18 Ribosomal protein L18 13.58 11 11
REPS1 (P) RalBP1 associated Eps domain containing protein (predicted) 10.73 12 12
LOC363720 chromatin modifying protein 2B 10.61 14 13
CNOT8 CCR4-NOT transcription complex, subunit 8 11.00 15 14
RTCD1 RNA terminal phosphate cyclase domain 1 10.48 17 15
RPL19 Ribosomal protein L19 13.74 13 16
NDUFB6 (P) NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 10.43 16 17
RPL9 Ribosomal protein L9 13.74 18 18
LOC499803 Similar to 40S ribosomal protein S3 13.76 19 19
RPL3 Ribosomal protein L3 14.03 20 20
ACTB Actin, beta 13.85
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 12.88
Microarray analysis of the expression profiles of 21,910 genes in naïve PC12 cells and those treated with NGF or GDNF for 0.5 h and 72 h. Twenty candidate
reference genes were selected based on pairwise comparison (geNorm) and model based variation (NormFinder) analysis of the top 100 genes with the lowest
CV. The log2 transformed values of the average signal intensities among the 24 arrays were shown as Mean. Thirteen of the twenty genes were Ribosomal
Protein Genes (Bold). Both ACTB and GAPDH were included for comparison but were not among the top 100 genes recommended by either statistical analysis.
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Page 3 of 13Figure 1 Neuronal differentiation of PC12 cells. A. Quantification of the percentage of PC12 cells bearing neurite of at least one cell body
length, after 72 h of treatment with NGF (50 ng/ml), GDNF (50 ng/ml), Forskolin (10 μM), KCl (5 mM) and ROCK inhibitor Y27632 (25 μM). GDNF
treatment was applied to PC12 cells stably expressing GDNF Family Receptor alpha 1a (GFRa1a) and co-receptor RET (either RET9 or RET51
isoforms), which were not endogenously expressed at detectable level in PC12 cells. All other stimulations were applied to wild type PC12 cells.
B. Representative images of control and treated PC12 cells immuno-stained with anti-Neurofilament 200 antibody.
Candidate Reference Genes HKGs
NGF regulated 
Genes
Figure 2 Distribution of the expression levels of genes examined. Box plot representation of the expression levels of twenty candidate
reference genes (solid line), two housekeeping genes (dashed line) and three target genes (dotted line) among the 120 biological samples. The
expression level of each gene was represented as the absolute copy number per unit input total RNA (0.0625 μg), quantified by RT-qPCR using
linearized plasmid standards. Primer design, assay efficiency and intra- and inter-assay variations were reported in supplementary data (Additional
File 1).
Zhou et al. BMC Genomics 2010, 11:75
http://www.biomedcentral.com/1471-2164/11/75
Page 4 of 13File 1). All RNA samples showed RQI values of greater
than 9, indicative of high quality and integrity (data
not shown).
Stabilities of candidate reference genes and common
housekeeping genes
Using both geNorm and NormFinder, we analyzed the
expression stabilities of the twenty candidate reference
g e n e sa n dt h et w oc o m m o n l yu s e dH K G sa c r o s sa l ls i x
differentiation conditions. Both statistical approaches
recommended the same three ribosomal protein genes
RPL19, RPL29 and RPL3 as the overall best reference
genes (Figure 3). Pairwise variation analysis by geNorm
showed that the combination of RPL19 and RPL29 is
sufficiently stable (V2/3 = 0.107, less than the recom-
mended cut-off of 0.15), thus excluding the need to
incorporate a third reference gene RPL3 for normaliza-
tion of target gene expression. Notably, neither GAPDH
nor ACTB were recommended.
Further analysis of candidate gene stabilities in each
treatment group (Additional File 2A) or at specific time
point (Additional File 2B) revealed that the stability
rankings of candidate genes do vary among different
subgroups. However, with the exception of RPL29 in
KCl treated samples, the two genes RPL19 and RPL29
were consistently ranked among top 5 in all subgroups.
In contrast, the stability rankings of GAPDH and ACTB
varied considerably among different subgroups and they
were ranked among the least stable ones within the
group of 22 genes in several subgroups. The data indi-
cated that the two novel candidate genes RPL19 and
RPL29 have higher expression stabilities than both
GAPDH and ACTB, and may serve as better normali-
zers for gene expression in neuronal differentiation of
PC12 cells.
Comparison of the normalization factors generated by
different reference gene(s)
To account for possible variations introduced during
sample preparation and measurements, raw expression
profiles of target genes were scaled by a normalization
factor (NF) calculated based on independent measure-
ment of one or more internal reference genes. The var-
iation between NFs generated by different reference
A
B
Figure 3 Stability analysis of candidate reference genes and housekeeping genes. Stability rankings of the twenty candidate reference
genes and two most commonly used housekeeping genes ACTB and GAPDH, among all 120 biological samples, by NormFinder (A) and
geNorm (B). A low ‘Stability Value’ or ‘M-value’ correlates to higher gene expression stability.
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final target gene expression values normalized by differ-
ent reference genes. We noticed that although RPL19
and RPL29 were ranked as the overall best pair of refer-
ence genes, they were not necessarily the best pair for
each treatment subgroup. To test the robustness of
these two genes across different treatments, we com-
pared the normalization factors calculated based on
R P L 1 9a n dR P L 2 9( N F RPL19/RPL29)t ot h a to ft h em o s t
stable pair of reference genes (NFtop2) in each treatment
subgroup. Similarly, we examined the differences
between NFtop2 and NFs calculated based on the com-
monly used HKGs, ACTB (NFACTB)o rG A P D H
(NFGAPDH). The deviations of each NF from NFtop2 are
represented in Figure 4 (see Additional File 3 for details
of calculation). The NFRPL19/RPL29 values were found to
least deviate from NFtop2 in NGF, GDNF and KCl sub-
groups, and had zero deviation in Fsk and Y27632 sub-
groups as RPL19 and RPL29 were ranked top 2. In
contrast, NFACTB and NFGAPDH differed substantially
from NFtop2 in many instances, reflective of their varying
stabilities across different treatments.
Effect of different reference genes on the interpretation
of target gene regulation
Next, the possibility that using scaling factors of
NFRPL19/29,N F ACTB or NFGAPDH may substantially alter
the interpretation of target gene expression regulation in
NGF induced neuronal differentiation was investigated.
The relative fold changes of EGR1, ITGA1 and CRYAB
expressions normalized by the three NFs were compared
to the values normalized by NF of the top 2 genes
(NFRPL29/RPL10A). No statistically significant differences
were observed among NFRPL29/RPL10A,N F RPL19/RPL29,
and NFACTB normalized values; whereas NFGAPDH nor-
malized fold changes were significantly different (Figure
5 A - C ) .I nt h ec a s eo fE G R 1a n dI T G A 1 ,t h eu s eo f
GAPDH as reference gene resulted in the underestima-
tion of target genes expressions, leading to false negative
conclusions when a two-fold cut off was applied (Figure
5A-B). On the other hand, normalization by GAPDH
resulted in the significant over-estimation of the down-
regulation of CRYAB in NGF treated samples (Figure
5C).
The clearly different expression profiles of EGR1,
ITGA1, and CRYAB when normalized to GAPDH raised
the possibility that GAPDH expression could be regu-
lated over the course of NGF induced differentiation.
Normalization of GAPDH expression by the NF of the
top 2 genes (NFRPL29/RPL10A)a n dt h eN F RPL19/RPL29,
revealed that GAPDH expression was indeed signifi-
cantly elevated (>2.5 fold at 24 h) in NGF-stimulated
PC12 cells (Figure 6). A more detailed analysis of the
kinetics of GAPDH expression over time revealed that
expression of GAPDH indeed increased over a period of
28 h (Additional File 4). As a result, the use of GAPDH
as a single, unverified reference gene would invariably
lead to erroneous interpretation of target gene
regulation.
Similarly, we investigated the effect of different refer-
ence gene(s) on normalized target gene expressions in
GDNF, Forskolin, KCl and ROCK inhibitor Y27632 trea-
ted samples. Similar to the case of NGF treatment, with
GDNF stimulated PC12-GFRa1a/RET9 and PC12-
Figure 4 Comparison of the normalization factors calculated using different reference gene(s). Normalization factors (NFs) calculated with
RPL19/RPL29, ACTB and GAPDH were compared to that calculated by the top 2 reference genes (NFtop2) as recommended by both NormFinder
and geNorm, for each stimulus. The percentage deviations of NFRPL19/RPL29;N F ACTB;N F GAPDH from NFtop2 (|NFx-NFtop2|/NFtop2) were represented
by box plot. The 25
th percentile to the 75
th percentile (boxes), and ranges (whiskers) were shown.
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in the underestimations of GDNF induced upregulation
of EGR1 and ITGA1 expressions; and over-estimated
CRYAB down-regulation (Additional File 5A, B). Inter-
estingly, normalization by ACTB was found to overesti-
mate the expression of EGR1 and ITGA1 expressions in
PC12-GFRa1a/RET51 but not RET9 cells (Additional
File 5B, 72 h), highlighting the subtle differences
between GFRa1a/RET9 and GFRa1a/RET51 systems.
For Forskolin and ROCK inhibitor Y23672 differen-
tiated samples, normalization by ACTB consistently led
to the over-estimations of target gene expressions
(Additional File 5C, D). Depending on the time point
analyzed, normalization by GAPDH was shown to result
in either underestimations or overestimations of target
gene expressions (Additional File 5C, D). In KCl treated
samples, no statistical significant difference was
observed among NFtop2 (RPL19/REPS1),N F RPL19/RPL29,
NFACTB and NFGAPDH normalized target gene expres-
sion, which suggested that all four were acceptable
reference gene(s) for this particular experimental condi-
tion (data not shown).
It is thus evident that the stabilities of the two most
commonly used HKGs, GAPDH and ACTB vary across
different experimental conditions during neuronal differ-
entiation of PC12 cells. They were acceptable reference
genes under some conditions but may significantly
under- or over-estimate target gene expression under
Figure 5 Fold changes in target gene expressions normalized using different reference gene(s). Fold changes in transcript expressions of
Egr-1 (A), Integrin alpha 1, ITGA1 (B), Crystallin alpha b, CRYAB (C), in NGF treated samples relative to that of control were normalized by (1)
geometric mean of RPL10a/RPL29; (2) geometric mean of RPL19/RPL29; (3) ACTB or (4) GAPDH. Normalization by GAPDH led to significant
quantitative underestimations of EGR1 and ITGA1 upregulation and overestimation of CRYAB downregulation. Dotted line represents the 2-fold
difference between treatment and control subjects, a cut off commonly used to distinguish significant changes from insignificant ones.
Significant differences between fold changes normalized by various reference gene(s) were calculated using the paired Student’s t-test. A value
of p < 0.05 was considered significant (**p < 0.01; *p < 0.05).
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ence genes RPL19 and RPL29 were stably expressed
among all conditions analyzed and allowed accurate
normalization of differentially regulated genes during
PC12 differentiation. It is worthy to note that at early
time points (0.5 h and 6 h), the expressions of EGR1,
ITGA1 and CRYAB did not show any significant differ-
ences when scaled with either NFtop2, NFRPL19/RPL29,
NFACTB or NFGAPDH (data not shown). This is consis-
tent with the observation that the expression of GAPDH
did not change significantly at the early time points
(Figure 6. and Additional File 4).
Discussion
Twenty candidate reference genes that showed little var-
iation but high expression in PC12 cells differentiated
with NGF and GDNF were first selected from microar-
ray datasets using two independent statistical algorithms.
Together with two well studied HKGs, the expression
stabilities of these candidate reference genes were
further analyzed using RT-qPCR in cells differentiated
with other stimuli. From these studies, unexpectedly,
RPL19 and RPL29 but not the HKGs, were identified as
suitable reference genes that can be used for normaliza-
tion of gene expression in neuronal differentiation of
PC12 induced by a variety of chemical stimuli.
Neuronal differentiation is a process where cells undergo
enormous morphological changes, over a period of several
days. It is accompanied by substantial biochemical changes
including cell cycle exit [36], changes in metabolism
[37,38] and alteration in structural proteins [39,40]. Since
the commonly used reference genes are mostly structural
proteins or enzymes involved in metabolism, it is espe-
cially important to validate the stabilities of these genes
during the process of differentiation. Many of these studies
investigated gene expression changes in PC12 but few
have evaluated the suitability of HKGs as normalizers in
this model. Our microarray analysis revealed that a group
of novel candidate genes was more stably expressed than
commonly used HKGs ACTB and GAPDH, suggesting
that ACTB and GAPDH may not be ideal reference genes
in neuronal differentiation of PC12 cells.
In an effort to gain an insight into the temporal regula-
tion of genes during neuronal differentiation, it is neces-
sary that the reference genes used are stably expressed
over a period of days. GAPDH and ACTB have been used
for normalization in more than 90% of previous reports
[41], often without proper validation of their stabilities.
Numerous publications have reported that such HKGs
can be differentially expressed under various experimental
paradigms and are therefore inappropriate for normaliza-
tion [9,15,16]. However, there are also recent reports that
these HKGs are stably expressed and can serve as refer-
ence genes [17,18,42]. Most genes, including GAPDH and
ACTB, examined in this study were stable at early stages
of differentiation (0.5 h or 6 h). However, as differentiation
proceeded with dramatic morphological changes and con-
comitant biochemical changes, the instability of expres-
sions of GAPDH and many of the genes examined was
obvious. In the case of GAPDH, this instability issue corre-
lated well with the temporal increase of expression level,
which peaked at 28 h and was sustained over a period of
72 h. While GAPDH may still serve as a reference gene
for PC12 cells under specific conditions, the validity of
Figure 6 Upregulation of GAPDH transcript expression in NGF induced neuronal differentiation. Fold changes in transcript expression of
GAPDH in NGF treated samples relative to that of control were normalized by (1) geometric mean of RPL10a/RPL29; or (2) geometric mean of
RPL19/RPL29. Dotted line represents the 2-fold difference between treatment and control cells.
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experimentally verified. However, the two RP genes
(RPL19 and RPL29) that showed good stability in expres-
sion over the period of differentiation provided an optimal
pair of reference genes for the entire period of and various
experimental conditions for neuronal differentiation.
Among the twenty candidate genes selected, thirteen
were ribosomal protein genes, suggesting that the family
of ribosomal protein genes may become yet another
source of reference genes. Several recent publications
have validated and recommended the use of ribosomal
protein genes as reference genes [23,25], while others
have reported their tissue-dependent variations [43]. A
plausible explanation for such disparity is the large
number of ribosomal protein genes present in mamma-
lian systems (80 genes in human, mouse and rat gen-
o m e ) ,w h i c hm a yb es t a b l yo rd i f f e r e n t i a l l ye x p r e s s e d
depending on the tissue type or experimental condi-
tions. At present, relatively little is known about these
mammalian ribosomal proteins, as compared to their
bacterial and archael counterparts [44]. While bacterial
ribosomal protein genes exist largely in clusters, the
mammalian RP genes are dispersed throughout the gen-
ome [45]. Some have suggested that all of these proteins
are intimately involved in ribosome production and
could be co-regulated. Depletion of a particular riboso-
mal protein would generally cause a reduction of all
other ribosomal proteins in the same ribosome sub-unit
[46]. Other reports have shown that some ribosomal
protein genes could be regulated independent of others
[47]. Recently, extra-ribosomal functions of some of
these proteins have been reported [48-51], suggesting
that they may be individually regulated. A previous
study comparing random ESTs from naïve and NGF-
treated PC12 cells, reported an NGF-promoted decrease
in the expressions of RPL19 [52]. However, this decrease
in RPL19 was not observed in other studies using SAGE
[53] or microarray [2]. Similar to the latter studies, we
too did not observe changes in RPL19 transcripts with
NGF-treated PC12. Moreover, the SAGE study but not
the microarray analysis reported a significant decrease
in RPL29 expression. Using both microarray and RT-
qPCR, we have also shown that RPL29 was unchanged
when the cells were differentiated. The reasons for these
discrepancies are unclear and may be due to the differ-
ences in methods used. We have shown here by quanti-
tative real-time PCR that some ribosomal protein genes,
RPL19 and RPL29, are highly stably expressed and are
thus suitable reference genes, whereas others like RPL9
and RPL18 can vary significantly during differentiation.
Unlike some studies that attempted to identify ideal
reference genes through meta-analysis of many publically
available microarray data which includes a diverse range
of tissue types and experimental conditions, this study was
designed to specifically identify a set of suitable reference
genes for PC12 cells undergoing neuronal differentiation.
We have performed both the microarray analysis and RT-
qPCR validation on biological samples prepared with the
same techniques and reagents, thus minimizing variations
introduced by differences in sample preparation methods
and assay platforms. We have also systematically evaluated
the effect of the use of NFs of inappropriate reference
gene(s) on the expression changes of the target genes and
the erroneous results they resulted in. Thus, with neuronal
differentiation of PC12 cells, scaling with the geometric
means of the expressions of RPL19 and RPL29 is recom-
mended for the accurate normalization of gene expression.
Whether these two genes are suitable for normalization of
neuronal differentiation in other systems remains to be
evaluated.
Conclusions
Twenty novel candidate reference genes were identified
and their expression stabilities were analyzed and com-
p a r e dt ot h a to fc o m m o n l yu s e dH K G sA C T Ba n d
GAPDH. Through this systematic study that included
both microarray analysis and RT-qPCR, we have found
two ribosomal protein genes RPL19, and RPL29 to be
stably expressed during neuronal differentiation of PC12
cells, induced by five different chemical stimuli, over 72
h. The combination of these two novel reference genes
a l l o w e dr o b u s ta n da c c u r a t en ormalization of differen-
tially expressed genes, regardless of stimuli and stages of
differentiation. In contrast, the use of an inappropriate
reference gene like GAPDH led to significant erroneous
estimation of differentially expressed genes.
Methods
Cell Culture
The rat pheochromocytoma cell line PC12 (catalog #
CRL-1721; American Type Culture Collection) cells
w e r eg r o w ni nD M E Ms u p p l e m e n t e dw i t h1 0 %h e a t -
inactivated fetal bovine serum (FBS; Hyclone, Logan,
UT) and 5% Horse Serum (HS), in a humidified atmo-
sphere with 5% CO2 a t3 7 ° C .W i l dt y p eP C 1 2c e l l s ,t h a t
do not endogenously express GFRa or RET (data not
shown), were co-infected with murine GFRa1a
(NM_010279) and RET9 (NM_001080780) or RET51
(NM_009050) in pQCXIN or pQCXIH vector by retro-
viral infection (Clontech, Mountain View, CA) and
selected with 0.4 mg/ml G418 and 0.1 mg/ml Hygromy-
cin, over a period of 2 months.
Differentiation, sample collection and assessment of
neurite outgrowth
Two million wild type or infected PC12 cells were
seeded in 75 cm
2 flask (NUNC, Finland) overnight, in
DMEM supplemented with 10% FBS and 5% HS,
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Page 9 of 13followed by serum depletion for 12 h. PC12 cells were
then treated with 50 ng/ml recombinant human GDNF
(Peprotech, NJ), 50 ng NGF (Peprotech, NJ), 10 μM For-
skolin (Sigma, St. Louis, MO), 5 mM KCl (Sigma, St.
Louis, MO) or 25 μM ROCK inhibitor Y27632 (Calbio-
c h e m ,U S A )i nD M E Mt oi n d u c en e u r i t eo u t g r o w t h .
Total RNA was isolated from control and treated cells
at 0.5, 6, 24 or 72 h. For neurite outgrowth assessment,
cells bearing at least one neurite with the length equiva-
lent to the cell bodies were scored at 72 h by indepen-
dent observers. More than 400 cells from three different
fields were counted per flask.
Immunocytochemistry
Control and treated PC12 Cells were fixed with 4% par-
aformaldehyde in 1xPBS for 15 min at 37°C, and subse-
quently in methanol at -20°C for an additional 15 min.
After three washes with 1xPBS, cells were permeabilized
and blocked with normal goat serum (1:10; Dako,
Glostrup, Denmark) in 0.5% Triton X-100/PBS for 30
min at 37°C. The cells were then incubated with high-
molecular-weight neurofilament protein (NF-200) anti-
body (Sigma, St. Louis, MO) at 1:80 dilution in 0.1%
Triton X-100/0.1% BSA/1xPBS for 1 h at 37°C and
washed three times in 1xPBS. Subsequently, the cells
were incubated with goat anti-rabbit fluorescent second-
ary antibody (Alexa Fluor 488; Invitrogen, CA) diluted
1:1000 in 0.1% Triton X-100/0.1% BSA/1xPBS for 1 h.
The cells were then washed three times in 1xPBS.
Image acquisition was performed using the Zeiss
inverted Axovert 25 microscope equipped with fluores-
cence detection (Oberkochen, Germany).
RNA Purification and cDNA Preparation
Total RNA from PC12 cells was prepared using TRIzol
reagent (Invitrogen, CA) according to manufacturer’s
instruction. Total RNA was collected from samples in
quadruplicate at each treatment time point and the integ-
rity of the RNA validated by denaturing agarose gel elec-
t r o p h o r e s i sa n du s i n gt h eS t d S e n sa n a l y s i sc h i po nt h e
Experion Automated Electrophoresis System (BioRad, CA)
according to manufacturer’si n s t r u c t i o n s .T h eE x p e r i o n
Automated Electrophoresis System assigns a RQI to each
RNA electropherogram which ranges from 10 (intact
RNA) to 1 (completely degraded RNA). RNA concentra-
tion was quantified using a NanoDrop ND-1000 spectro-
photometer (Thermo Scientific, Wilmington, DE), and the
260/280 and 260/230 ratios were examined for protein
and solvent contamination. Five micrograms of total RNA
were reverse transcribed in a total volume of 20 μlc o n -
taining 400 U of ImpromII and 0.5 μgo fr a n d o mh e x a m e r
(Promega, Madison, WI) for 60 min at 42°C according to
the manufacturer’s instructions. The reaction was
terminated by heating at 70°C for 5 min, and the cDNA
was diluted 1:20 for quantitative real-time PCR.
Microarray
PC12 cells were seeded on 25 cm
2 flask in complete med-
ium and subsequently incubated for 12 h in serum free
DMEM. The cells were then treated with GDNF (50 ng/
ml) or NGF (50 ng/ml) for 0.5 h or 72 h in duplicates.
Total RNA was isolated, quantified and integrity verified
before it was amplified using Ambion Illumina RNA
Amplification kit (Ambion, TX, USA). Briefly, total RNA
(500 ng) was reverse transcribed by ArrayScript in the pre-
sence of T7 Oligo(dT) primer. Second strand of the cDNA
was synthesized by DNA polymerase at 16°C for 2 h. The
cDNA was purified and in vitro transcribed with T7 RNA
polymerase and biotin-NTPs. Biotin-labeled cRNA sam-
ples were purified and quantified by ND-1000 spectro-
photometer (NanoDrop, Fisher Thermo, DE, USA). Each
cRNA (750 ng) was hybridized to RatRef-12 Expression
BeadChip (Illumina, San Diego, CA, USA) containing
22,523 probes for a total of 21,910 rat genes selected pri-
marily from the NCBI RefSeq database (Release 16)
according to instruction provided by Experienced User
Card (11286340 Rev A, Illumina). After hybridization,
washing and blocking, the BeadChip was incubated with
Streptavidin-Cy3 solution (Amersham Biosciences, Piscat-
away, NJ, USA). Fluorescent signals were obtained from
scans on the high resolution Illumina BeadArray reader,
using a two-channel, 0.8 μm resolution confocal laser
scanner. The Illumina BeadStudio software (Version 2.0)
was used to extract fluorescence intensities and the raw
fluorescent data was background subtracted and used for
analysis. Background is defined as the average signal inten-
sity estimated from the negative control bead types. Out-
liers are removed using the median absolute deviation
method. Detection p-values produced by the BeadStudio
software were corrected for multiple hypothesis testing.
Primer Design and Plasmid Standards
The Genbank accession for each candidate reference
gene was retrieved from the Illumina microarray probe
set and compared to the NCBI RefSeq database (Release
16; http://www.ncbi.nlm.nih.gov. Transcript splicing
sites were retrieved from Ensembl http://www.ensembl.
org. Where more than one transcript matched the
probe, the sequences were aligned and the primers were
designed to amplify the consensus region. Vector NTI
Advance 10 was used to design two sets of primers for
each target gene. The first set of primers generates an
amplicon of ~300 bp and is used as a template for RT-
qPCR of the targeted gene. The template was subcloned
into pGEMT-easy (Promega) vector as previously
described [54]. The second set of primers was used for
RT-qPCR and was designed to amplify a ~100 bp region
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exon spanning to avoid amplification from genomic
sequences. Where possible, primers for RT-qPCR were
designed to target the same exons used in the Illumina
Expression BeadChip. All primer sequences were evalu-
ated for possible false priming to known rat sequences
using the NCBI BLAST tool http://blast.ncbi.nlm.nih.
gov/. All products generated after amplifications were
verified by gel-electrophoresis and DNA sequencing.
Quantitative Real-Time PCR
Real-time PCR was performed on Biorad iCycler 4
Real-Time PCR Detection System (Bio-Rad, Hercules,
CA) using SYBR Green I. The threshold cycles (Ct)
were calculated using the iQ5 Optical system software
version 2.0. Real-time PCR was performed after an
initial denaturation for 10 min at 95°C, followed by 40
cycles of 30 s denaturation at 95°C, 30 s annealing at
60°C, and 30 s extension at 72°C. Fluorescent detection
was performed at the annealing phase. Melt curve ana-
lysis was carried out at the end of the cycling to con-
f i r mt h a tas i n g l ep r o d u c thad been amplified. Primer
dimer formation in all the assays showed distinct melt
characteristics from the correct amplicons. The reac-
tion was performed in a total volume of 40 μli n1 ×
XtensaMix-SG (BioWORKS, Singapore), containing 2.5
mM MgCl2, 10 pmol of each primer, and 0.5 U of
KlearTaq Hotstart DNA polymerase (KBioscience, UK).
All real-time PCR quantification was performed simul-
taneously with linearized plasmid standards and a non-
template control [54]. As PCR is an exponential pro-
cess, it can be described by the equation, Nn =N 0(1 +
ε)
n,w h e r eN n is the number of target molecules at
cycle n, N0 is the initial number of target molecules, ε
is the efficiency of amplification and n is the number
of cycles. The efficiency of target amplification of an
assay was determined from the slope of a plot of Ct
(Threshold cycle) versus -log10 concentration of the
initial number of target molecules. High efficiency of
amplification has a slope approaching the value of 3.32
cycles for every 10-fold dilution of the target. The
gene expression levels were interpolated from standard
curves and expressed as absolute copy numbers. All
Real-time PCR experiments were compliant with the
MIQE (Minimum Information for Publication of
Quantitative Real-Time PCR Experiments) guidelines
[55].
Statistical data analysis
Gene expression stability analysis using two publicly
available software tools, geNorm http://medgen.ugent.
be/genorm/ and NormFinder http://www.mdl.dk/, were
carried out according to authors’ instruction.
Additional file 1: RT-qPCR assay design and performance. Efficiencies
of amplification and inter/intra-assay precisions of the assays used to
measure the twenty candidate reference genes, two commonly used
housekeeping genes and three target genes quantified in this study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
75-S1.ZIP]
Additional file 2: Stability rankings of twenty candidate reference
genes, ACTB and GAPDH in treatment and time-point subgroups.
Stability rankings were determined by NormFinder (Italic) and geNorm, for
each stimulus (Additional File 2A) or time point (Additional File 2B)
subgroup. The top two candidate genes (RPL19 and RPL29) in overall
ranking (Figure 4) were bolded in red and the two HKGs were bolded
and highlighted in grey.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
75-S2.ZIP]
Additional file 3: Calculations of the deviation from NFtop2.
Illustration of the calculation of the deviation of different normalization
factors (NFRPL19/RPL29;N F ACTB and NFGAPDH ) from NFtop2 (NFRPL10A/RPL29 for
NGF group), in 12 control and 12 NGF treated samples.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
75-S3.PDF]
Additional file 4: Time course analysis of GAPDH expression in NGF
induced PC12 differentiation. A detailed time course analysis showing
the up-regulation of GAPDH transcript expression by NGF treatment in
PC12 cells, normalized by the geometric mean of RPL19 and RPL29.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
75-S4.PDF]
Additional file 5: Normalized target gene expression regulation in
PC12 cells differentiated with GDNF, Forskolin and Y27632.F o l d
changes in transcript expressions of Egr-1 (i), Integrin alpha 1, ITGA1 (ii),
and Crystallin alpha b, CRYAB (iii), in GDNF-GFRa1a-RET9 (A), GDNF-
GFRa1a-RET51 (B), Forskolin (C), Y27632 (D) treated samples relative to
that of control were normalized by geometric mean of top 2 reference
genes in each subgroup; geometric mean of RPL19/RPL29; ACTB or
GAPDH. Normalization by ACTB resulted in the over-estimation of target
gene expression. Normalization by GAPDH led to either under- or over-
estimation of target gene expression. Dotted line represents the 2-fold
difference between treatment and control subjects, a cut off commonly
used to distinguish significant changes from insignificant ones.
Significant differences between fold changes normalized by various
reference gene(s) were calculated using the paired Student’s t test.A
value of p < 0.05 was considered significant (**p < 0.01; *p < 0.05)
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
75-S5.DOCX]
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